Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptide corresponding to a region within amino acids 344 and 435 of Human VPAC2|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 10% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-27162 targets VPAC2 in WB applications and shows reactivity with Human samples.
The PA5-27162 immunogen is synthetic peptide corresponding to a region within amino acids 344 and 435 of Human VPAC2.
Vasoactive intestinal peptide (VIP; MIM 192320) and pituitary adenylate cyclase activating polypeptide (PACAP; MIM 102980) are homologous peptides that function as neurotransmitters and neuroendocrine hormones. While the receptors for VIP and PACAP share homology, they differ in their substrate specificities and expression patterns. See VIPR1 (MIM 192321) and ADCYAP1R1(MIM 102981).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
helodermin-preferring VIP receptor; PACAP type III receptor; PACAP-R-3; PACAP-R3; pituitary adenylate cyclase-activating polypeptide type III receptor; SCZD16; vasoactive intestinal polypeptide receptor 2; VIP and PACAP receptor 2; VPAC2R; VPCAP2R
C16DUPq36.3; DUP7q36.3; PACAP-R-3; PACAP-R3; VIP-R-2; VIP2R; VIPR2; VPAC2; VPAC2R; VPCAP2R